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Background: The struggle against social inequalities is a priority for many international organizations. The objective
of the study was to quantify the cancer burden related to social deprivation by identifying the cancer sites linked to
socioeconomic status and measuring the proportion of cases associated with social deprivation.
Methods: The study population comprised 68 967 cases of cancer diagnosed between 1997 and 2009 in
Normandy and collected by the local registries. The social environment was assessed at an aggregated level
using the European Deprivation Index (EDI). The association between incidence and socioeconomic status was
assessed by a Bayesian Poisson model and the excess of cases was calculated with the Population Attributable
Fraction (PAF).
Results: For lung, lips-mouth-pharynx and unknown primary sites, a higher incidence in deprived was observed
for both sexes. The same trend was observed in males for bladder, liver, esophagus, larynx, central nervous
system and gall-bladder and in females for cervix uteri. The largest part of the incidence associated with deprivation
was found for cancer of gall-bladder (30.1%), lips-mouth-pharynx (26.0%), larynx (23.2%) and esophagus (19.6%) in males
and for unknown primary sites (18.0%) and lips-mouth-pharynx (12.7%) in females. For prostate cancer and melanoma
in males, the sites where incidence increased with affluence, the part associated with affluence was respectively 9.6%
and 14.0%.
Conclusions: Beyond identifying cancer sites the most associated with social deprivation, this kind of study points to
health care policies that could be undertaken to reduce social inequalities.
Keywords: Cancer incidence, Socioeconomic inequalities, Registries, Population attributable fractionBackground
Cancer is one of the leading causes of mortality worldwide
and the second in the developed countries. It is thought to
be responsible for around 13% of the total number of
deaths, approximately 7.6 million persons dying from can-
cer in 2008. While cancer survival continues to improve
essentially thanks to progress in treating patients and to
screening, the observations concerning incidence are
much less encouraging. Social deprivation can be singled
out as responsible for part of this cancer incidence and the* Correspondence: josephine.bryere@inserm.fr
1U1086 INSERM Cancers & Preventions, Avenue du Général Harris, Caen
14076, France
Full list of author information is available at the end of the article
© 2014 Bryere et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.struggle against social inequalities in cancer constitutes a
priority for international organizations [1].
Public action to reduce this gradient must rely in part
on the proper assessment of the burden of cancer asso-
ciated with social environment and on the knowledge of
the mechanisms underlying such inequalities.
Studies of this type have initially focused on mortality
data [2,3]. But it is important to differentiate between so-
cial disparities in incidence of cancer and social disparities
in survival as it was the case in the literature of the recent
years. The relationship between cancer incidence and so-
cioeconomic status is dynamic and needs to be continu-
ously monitored.
The mechanisms by which the social environment in-
fluences the risk of cancer are many and varied. None ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Bryere et al. BMC Cancer 2014, 14:87 Page 2 of 10
http://www.biomedcentral.com/1471-2407/14/87these mechanisms are exclusive and all interact. Based on
the work of previous authors, these mechanisms are orga-
nized in behavioral models focusing on individual deter-
minants [4,5] (alcohol, tobacco, diet, physical exercise,
practice prevention, etc.), or contextual models focusing
on complexity determinants [6,7] (occupational exposure,
general exposure, access to health system, etc.). This com-
plexity suggests that a proper evaluation of the social
environment should not be limited to any particular indi-
cator such as financial resources, education or profession,
but should appreciate the social environment in its entire
individual and collective dimension. Geographical ap-
proaches are thus particularly relevant for studying the
link between social environment and cancer incidence.
Moreover, from a public health point of view, the measure
of the human cost of these inequalities at an aggregated
level is particularly relevant for potential further actions.
The objective of the study was to quantify the part of
the cancer burden related to social deprivation. We firstly
identified the cancer sites linked to the socioeconomic sta-
tus of the living area and secondly measured for each one




The population comprised all cases of cancer diagnosed in
Calvados and Manche, two French departements in Basse-
Normandie, from 1997 to 2009 and recorded in the five
local registries: Calvados cancer registry, digestive Calvados
registry, Manche cancer registry, Malignant hematological
Basse-Normandie registry and Multicentral mesothelioma
registry. The whole population comprised 68 967 cases di-
vided into 29 cancer sites (Table 1). According from INSEE
(Institut National de la Statistique et des Etudes Economi-
ques), the population of Calvados and Manche is composed
of 48% of men and 52% of women which is equivalent to
the national distribution. The population is slightly older
than the national average. In Calvados and Manche, 47% of
individuals are under 40 years compared to 50% nationally,
and 26% are over 60 years compared to 23% nationally.
The economy is also less efficient with a GDP of 2.1%; it
stands at 3.1% nationally.
Variables
The clinical characteristics of the tumors were collected
by the registries in a standardized way ensuring the com-
pleteness and good quality of the data. The site, morph-
ology, age, gender and diagnosis date were known for
every patient.
For all cases of cancer diagnosed, place of residence
was geolocalized with a Geographic Information System
(GIS) running on MAPINFO 10.0 and allocated to an
IRIS (Ilots Regroupes pour l'Information Statistique), ageographical area defined by INSEE [8]. It is the smallest
geographical unit for which census data are known, a fac-
tor essential for this kind of study [9]. There are 1496 IRIS
in the two departments. The smallest IRIS is composed of
10 inhabitants, the biggest is composed of 4811 inhabitants
and the mean is 755. The database provided the number of
cancer cases diagnosed in an IRIS for the whole period.
The reference population came from the INSEE social
census 1999 and 2006. It is given for each IRIS, each sex
and each age group: [0–14], [15–29], [30–44], [45–59],
[60–74], [75 and more]. The population was linearly ex-
trapolated for the whole period 1997–2009. Knowing the
population sizes for an IRIS, an age group and a gender
for the years 1999 and 2006, supposing that an increase or
a decrease of the sizes were constant, we extrapolated the
population sizes for the years 1997, 1998, 2000, 2001,
2002, 2003, 2004, 2005, 2007, 2008, 2009.
The recently published French EDI (European Deprivation
Index) was used to attribute a social deprivation score
to the IRIS [10]. The methodology used an individual
deprivation indicator from the conceptual definition of
deprivation and selected ecological census variables that
are the most closely related to the individual deprivation
indicator in the European Union Statistics on Income and
Living Conditions (EU-SILC). This was available as a con-
tinuous variable, increasing from - 5.33 to 20.52. Depend-
ing on the modelling performed, the continuous version
of the EDI variable or a categorical version (quintiles cal-
culated at the French level) was used.
Statistical analysis
A Bayesian approach was used rather than the classical
Poisson regression because it allows the integration of
extra-Poisson variability if it exists in the data. The dif-
ferences in population sizes between IRIS, called un-
structured spatial heterogeneity, may have introduced
variations and this methodology permits the distinction
between random fluctuations and true variations in inci-
dence rates. Moreover, neighboring areas may not be in-
dependent and have similar incidence rates and this
phenomenon, called spatial autocorrelation, is also inte-
grated with the Bayesian approach [11,12] performed
using WinBUGS version 1.4 [13]. It is written as follows:
log yið Þ ¼ log Eið Þ þ αþ β EDIi þ V i þ Ui
where yi and Ei are the observed and expected number of
cases in area i. Ei ¼
X
j;k
tj;kPj;k where tj,k is the global inci-
dence rate for the age group j and sex k and Pj,k is the
population size for the IRIS i, age group j and sex k. α is
the intercept, representing the global relative risk, β the
coefficient associated with the variable EDI, Ui is the struc-
tured variation (spatially structured heterogeneity) and Vi
Table 1 Site definitions and frequencies in Normandy between 1997 and 2009
Site ICD-O-3 Frequencies
Topographya Morphologya Men Women Total
Prostate C61 All 11611 11611
Breast C50 All 10893 10893
Lung C33, C34 All 6095 1324 7419
Colon-rectum C18, C19, C20, C21 All 3983 3206 7189
Lips-mouth-pharynx C0, C10, C11, All 3153 579 3732
C12, C13, C14 All
Bladder C67 All 2452 590 3042
Kidney C64, C65, C66, C68 All 1334 737 2071




Stomach C16 All 1186 691 1877
Melanoma C44 87203-87803 725 1063 1788
Unknown primary sites C76, C809, All 925 654 1579
Central nervous system C70, C71, C72 ≤ 91103 or ≤91800 719 801 1520
Corpus uteri C54 All 1449 1449
Pancreas C25 All 786 660 1446
Liver C22 All 1148 238 1386
Esophagus C15 All 1138 208 1346
Ovary C56, C570, C571, All excluding 1247 1247
C572, C573, C576 {84423; 84513;
84613; 84623;
84723; 84733}
Myeloma All 97313-97343 or 646 543 1189
97603-97643
Thyroid C73 All 258 884 1142
Larynx C32 All 867 86 953
Lymphocytic leukemia All 98233 508 409 917
Cervix uteri C53 All 764 764






Gall bladder and extrahepatic bilary tract C23, C24 All 185 254 439
Testis C62 All 400 400
Hodgkin’s lymphoma All 96503-96673 209 155 364
Mesothelioma C384 All 190 60 250
Small intestine C17 All 98 91 197
All cancers C00 to C80 All 40080 28887 68967
aHematological codes are always excluded from solid tumor sites and included in the relevant hematological site.
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erogeneity). The EDI coefficient was estimated with its
95% credible intervals (CIs) for each cancer site. A positive
EDI parameter means an over-incidence in deprived areas
and a negative EDI parameter means an over-incidence in
affluent areas. We calculated exp (β) for significant sites
because it reflects the excess risk related to EDI. Living in
an IRIS with a highest deprivation score of one over an-
other, increases the risk of developing a cancer of exp (β).
To know whether spatial autocorrelation and spatial
heterogeneity were actually in the data, we first per-
formed a Moran test [14] for autocorrelation and a
Potthoff-Wintinghill test [15] for heterogeneity. They
were performed with packages spdep and DCluster
from R version 2.15.0, p-values of the tests being indi-
cated in tables. If both tests were significant we per-
formed a BYM (Besag, York and Mollié) model
integrating the two components, if just the Moran test
was significant we performed a CAR (Conditional Auto
Regressive) model integrating the spatially structured
heterogeneity, if just the Potthoff-Wintinghill test was
significant we performed a model with the non-
spatially structured heterogeneity and if both tests
were non-significant, meaning that there was no vari-
ability of incidence in the data, the integration of EDI
was not included in the analysis.
The final step was to assess for each cancer site the
Population Attributable Fraction (PAF) [16,17]. It can be
defined [16] as the proportional reduction in average
disease risk over a specified time interval that would be
achieved by eliminating the exposure of interest from
the population. To do so, the national quintile version of
the deprivation index EDI was used and included in the
model. The quintiles were named Q1 to Q5, Q1 being the
quintile of the least deprived group and Q5 the quintile
of the most deprived one. A relative risk was determined
for each social deprivation level and was called RR1 to
RR5. The relative risks were calculated using the exact
same model as above, except that the categorical version
of the EDI (by quintile) was introduced into the model.
If a significant and a positive beta coefficient were ob-
served, then Q1 was considered as the reference cat-
egory. If a significant and a negative beta coefficient
were observed, then Q5 was considered as the reference
category. The relative risk of the reference category was
set to 1. The associated proportion of risk was defined
as:
PAF ¼ 1− 1X
i¼1::5piRRi
Pi is the proportion of the population at the national
quintile i.Results
For the whole study period, 68 967 cases of cancer were
recorded in Calvados and Manche, 40 080 men and 28
887 women.
The most frequent sites in decreasing order were pros-
tate, breast, lung, colon-rectum and lips-mouth-pharynx
(Table 1).
Concerning the continuous deprivation index EDI, the
minimum was −3.77 for the most affluent IRIS and the
maximum was 8.98 for the most deprived IRIS, the me-
dian being −0.45. Quintiles being defined at a national
level, 20% of the population was situated at the first
quintile, 22% at the second, 23% at the third, 23% at the
fourth and 12% at the fifth.
Tables 2 and 3 present the results of modelling using
the continuous version of EDI.
The Potthoff-Whittinghill test and the Moran test
were significant for a majority of sites.
The link between incidence and social deprivation was
not significant for a majority of cancer sites in both gen-
ders, was positive for 9 sites in males and 4 sites in females
and was negative for two in males and none in females.
For lung, lips-mouth-pharynx and unknown primary sites,
the link was positive in both genders. We obtained similar
betas for both genders but the sites concerned were more
frequent in males so the impact in terms of number of
cases was greater in males. The link was positive in males
only for bladder, liver, esophagus, larynx, central nervous
system and gall-bladder and in females only for cervix
uteri. The highest relative risks concerned lips-mouth-
pharynx in both genders, larynx and gall-bladder in males
and cervix uteri in females.
Tables 4 and 5 present the relative risks calculated
using the quintile version of EDI and the results of the
calculation of the PAF.
Using the calculation of PAF, the greatest part of the
incidence associated with deprivation was found for lips-
mouth-pharynx cancer, esophageal cancer, laryngeal can-
cer and gall-bladder in males, respectively 26.0%, 19.6%,
23.2% and 30.1%. In females, the greatest part of the in-
cidence associated with deprivation was found for un-
known primary sites (18.0%) and lips-mouth-pharynx
(12.7%). For prostate cancer and melanoma in males, the
sites where incidence increased with affluence, the part as-
sociated with affluence was respectively 9.6% and 14.0%.
The excess cases due to social deprivation are represented
in Figures 1 and 2. The highest number of cases attribut-
able to social deprivation concerned lips-mouth-pharynx
cancer in males (n = 820) (Figure 1) and unknown primary
sites (n = 120) (Figure 2) in females and for prostate can-
cer, 1115 cases can be considered as excess cases due to
affluence and for melanoma in males, 90 cases can be con-
sidered as excess cases due to affluence. By adding excess
cases associated with deprivation, we find 2287 excess
Table 2 Influence of socioeconomic deprivation of living area on cancer incidence in men in Normandy between 1997
and 2009
Site Moran test PW test Estimationa CIb (95%) Exp (β)
p-value p-value EDI coefficient
Prostate 0.33 < 0.05 −0.023 [−0.043; -0.010] 0.98
Lung < 0.025 < 0.05 0.087 [0.065; 0.108] 1.09
Colon-rectum < 0.025 < 0.05 0.025 [−0.001; 0.050]
Lips-mouth-pharynx < 0.025 < 0.05 0.149 [0.122; 0.176] 1.16
Bladder < 0.025 < 0.05 0.033 [0.001; 0.064] 1.03
Kidney <0.025 < 0.05 0.033 [−0.003; 0.069]
Stomach < 0.025 < 0.05 0.001 [−0.047; 0.047]
Liver < 0.025 < 0.05 0.076 [0.039; 0.114] 1.08
Esophagus < 0.025 < 0.05 0.086 [0.043; 0.131] 1.09
Non-Hodgkin lymphoma 0.04 < 0.05 −0.006 [−0.047; 0.035]
Unknown primary sites 0.11 < 0.05 0.060 [0.019; 0.101] 1.06
Larynx < 0.025 < 0.05 0.154 [0.114; 0.196] 1.17
Pancreas 0.65 < 0.05 0.019 [−0.029; 0.066]
Melanoma 0.86 < 0.05 −0.078 [−0.132; -0.026] 0.92
Central nervous system < 0.025 < 0.05 0.056 [0.010; 0.101] 1.06
Myeloma 0.84 < 0.05 −0.024 [−0.080; 0.030]
Lymphocytic leukemia 0.98 < 0.05 −0.040 [−0.105; 0.023]
Testis < 0.025 < 0.05 −0.029 [−0.094; 0.036]
Leukemia 0.43 < 0.05 −0.013 [−0.080; 0.052]
Thyroid 0.09 < 0.05 0.020 [−0.057; 0.095]
Hodgkin’s lymphoma 0.16 < 0.05 −0.085 [−0.180; 0.005]
Gall-bladder and < 0.025 < 0.05 0.141 [0.058; 0.221] 1.15
Extrahepatic bilary tract
Mesothelioma < 0.025 < 0.05 0.057 [−0.172; 0.052]
Small intestine 0.69 < 0.05 0.009 [−0.127; 0.135]
aPositive for an over-incidence in deprived areas, negative otherwise.
bSignificant CIs are in bold type.
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and 353 in females (1.2% of the total number of cancer in
females).
Discussion
This study provides evidence of social disparities in the
incidence of cancers. Most of these disparities consist in
an over-incidence for the most deprived, especially for
lips-mouth-pharynx, lung, unknown primary sites, blad-
der and larynx cancers. Both genders are concerned, but
the impact is greater in men, considering the huge fre-
quency of these cancer sites for them. These inequalities
in incidence are all the more serious and the cancer bur-
den is all the greater in that the cancer sites concerned
are those associated with very low survival. For the
period 1997–2009, analysis with the PAF showed that
the social gradient generated 2287 (5.7%) excess cases in
men and 353 (1.2%) in females. By analyzing site by site,the social gradient generated up to 30.1% (gall-bladder)
and 18.0% (unknown primary sites) extra cases in men
and women respectively.
The sites identified as linked with socioeconomic
status are not surprising and consistent with previous pa-
pers. Thus, the highest incidence for lung, lips-mouth-
pharynx, esophagus, larynx, bladder and liver cancer in
low socioeconomic status can be explained by a higher
consumption of alcohol and tobacco in the most disad-
vantaged [5,18,19]. Similarly, the trend in over-incidence
of cervical cancer in deprived women can be explained
by sexual behaviors and/or lower participation in pap
smear screening [20]. The highest incidence of cancers
with unknown primary sites in males and females with
a low socioeconomic status can be explained by the fact
that the group of “unknown primary sites” mainly com-
prised subjects with metastatic cancers where the pri-
mary site could not be identified, a situation more
Table 3 Influence of socioeconomic deprivation of living area on cancer incidence in females in Normandy between
1997 and 2009
Site Moran test PW test Estimationa CIb (95%) Exp (β)
p-value p-value EDI coefficient
Breast < 0.025 < 0.05 −0.016 [−0.032; 0.001]
Colon-rectum < 0.025 < 0.05 −0.001 [−0.026; 0.026]
Corpus uteri < 0.025 < 0.05 0.024 [−0.011; 0.059]
Lung < 0.025 < 0.05 0.075 [0.037; 0.113] 1.08
Ovary 0.69 < 0.05 −0.031 [−0.069; 0.006]
Melanoma 0.49 < 0.05 −0.028 [−0.068; 0.012]
Non-Hodgkin lymphoma 0.79 < 0.05 −0.004 [−0.046; 0.038]
Thyroid < 0.025 < 0.05 0.002 [−0.043; 0.047]
Central nervous system < 0.025 < 0.05 0.024 [−0.044; 0.051]
Cervix uteri < 0.025 < 0.05 0.094 [0.052; 0.136] 1.10
Kidney < 0.025 < 0.05 0.021 [−0.026; 0.068]
Stomach < 0.025 < 0.05 0.007 [−0.052; 0.067]
Pancreas 0.05 < 0.05 0.045 [−0.004; 0.091]
Unknown primary site 0.56 < 0.05 0.065 [0.015; 0.113] 1.08
Bladder < 0.025 < 0.05 0.033 [−0.023; 0.086]
Lips-mouth-pharynx < 0.025 < 0.05 0.103 [0.054; 0.150] 1.11
Myeloma 0.35 < 0.05 −0.038 [−0.096; 0.020]
Lymphocytic leukemia < 0.025 < 0.05 0.041 [0.024; 0.104]
Leukemia 0.04 < 0.05 −0.036 [−0.107; 0.034]
Gall-Bladder and 0.93 < 0.05 −0.014 [−0.097; 0.068]
Extrahepatic bilary tract
Liver < 0.025 < 0.05 0.078 [−0.002; 0.154]
Esophagus 0.40 < 0.05 0.068 [−0.017; 0.151]
Hodgkin’s lymphoma 0.33 0.11
Small intestine 0.88 0.14
Larynx < 0.025 0.06 0.110 [−0.005; 0.217]
Mesothelioma < 0.025 0.05 0.040 [−0.144; 0.205]
aPositive for an over-incidence in deprived areas, negative otherwise.
bSignificant CIs are in bold type.
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[21]. Results in the literature concerning the relation
between incidence of central nervous system cancer so-
cioeconomic status are contradictory. The etiology of
cerebral tumors remains unclear [22,23]. The results
concerning gall-bladder are consistent with previous
papers. People with a low socioeconomic status may
have a diet and a feeding behavior which contribute to a
development of the disease [24]. The trend in over-
incidence of prostate cancer may come from the higher
participation of high socioeconomic classes in screening
activities and since PSA screening is associated with over
diagnosis [25]. The higher participation of high socioeco-
nomic classes in screening activities can also explain the
higher incidence for affluent patients for melanoma in
males and this higher incidence can also be explained byholidays abroad and exposure to natural UV [17,26]. Con-
versely, the absence of a social gradient in the incidence of
breast seems surprising, since it is targeted by screening
associated with social inequalities in participation, and
because well-established risk factors such as late age at
first birth or hormone replacement are more prevalent
in high socioeconomic groups [6]. The spatial nature of
the data and its specificities (spatial autocorrelation and
non spatially structured heterogeneity) was accounted in
our modelling thanks to the Bayesian approach ensuring a
good consistency of the statistical analysis. Such a method-
ology was not integrated in previous studies treating can-
cer incidence and social disparities, preferring a classical
Poisson regression, and thus risking to underestimate the
standard error and to wrongly conclude at a significant ef-
fect of deprivation on cancer incidence [27].
Table 4 Analysis using the quintile version of EDI and
Population Attributable Fraction in males between 1997
and 2009
Site RR CI PAFa (%)
Prostate Quintile 1 1.19 [1.09; 1.29] 9.6
Quintile 2 1.13 [1.04; 1.22]
Quintile 3 1.04 [0.96; 1.12]
Quintile 4 1.15 [1.06; 1.24]
Quintile 5 1
Lung Quintile 1 1 9.9
Quintile 2 1.07 [0.97; 1.19]
Quintile 3 0.99 [0.88; 1.10]
Quintile 4 1.18 [1.06; 1.31]
Quintile 5 1.44 [1.29; 1.61]
Lips-mouth-pharynx Quintile 1 1 26.0
Quintile 2 1.23 [1.06; 1.43]
Quintile 3 1.20 [1.03; 1.39]
Quintile 4 1.54 [1.34; 1.78]
Quintile 5 2.05 [1.77; 2.05]
Bladder Quintile 1 1 6.0
Quintile 2 1.10 [0.95; 1.27]
Quintile 3 0.93 [0.80; 1.09]
Quintile 4 1.51 [0.99; 1.34]
Quintile 5 1.19 [1.01; 1.40]
Liver Quintile 1 1 6.9
Quintile 2 1.04 [0.85; 1.27]
Quintile 3 0.93 [0.75; 1.14]
Quintile 4 1.14 [0.94; 1.38]
Quintile 5 1.40 [1.15; 1.71]
Esophagus Quintile 1 1 19.6
Quintile 2 1.30 [1.05; 1.63]
Quintile 3 1.17 [0.95; 1.47]
Quintile 4 1.24 [1.01; 1.54]
Quintile 5 1.67 [1.34; 2.11]
Unknown primary sites Quintile 1 1 9.7
Quintile 2 0.99 [0.79; 1.26]
Quintile 3 1.12 [0.89; 1.41]
Quintile 4 1.18 [0.95; 1.47]
Quintile 5 1.13 [1.03; 1.65]
Larynx Quintile 1 1 23.2
Quintile 2 1.05 [0.81; 1.35]
Quintile 3 1.24 [0.98; 1.58]
Quintile 4 1.54 [1.22; 1.95]
Quintile 5 1.91 [1.49; 2.45]
Table 4 Analysis using the quintile version of EDI and
Population Attributable Fraction in males between 1997
and 2009 (Continued)
Melanoma Quintile 1 1.37 [1.07; 1.77] 14.0
Quintile 2 1.16 [0.89; 1.49]
Quintile 3 1.06 [0.82; 1.37]
Quintile 4 1.18 [0.92; 1.50]
Quintile 5 1
Central nervous system Quintile 1 1 9.4
Quintile 2 1.05 [0.81; 1.35]
Quintile 3 1.16 [0.91; 1.47]
Quintile 4 1.15 [0.90; 1.44]
Quintile 5 1.19 [0.93; 1.54]
Gall-bladder Quintile 1 1 30.1
Quintile 2 1.59 [0.94; 2.80]
Quintile 3 1.32 [0.77; 2.27]
Quintile 4 1.31 [0.90; 2.60]
Quintile 5 1.88 [1.11; 3.24]
aPAF calculated with quintile 1 as reference except for prostate cancer
and melanoma.
Table 5 Analysis using the quintile version of EDI and
Population Attributable Fraction in females between
1997 and 2009
Site RR CI PAFa (%)
Lung Quintile 1 1 9.0
Quintile 2 1.09 [0.88; 1.35]
Quintile 3 1.12 [0.84; 1.29]
Quintile 4 1.10 [0.89; 1.35]
Quintile 5 1.37 [1.11; 1.71]
Cervix uteri Quintile 1 1 5.2
Quintile 2 0.88 [0.67; 1.15]
Quintile 3 1.05 [0.81; 1.35]
Quintile 4 1.09 [0.86; 1.39]
Quintile 5 1.40 [1.10; 1.80]
Unknown primary sites Quintile 1 1 18.0
Quintile 2 1.21 [0.89; 1.65]
Quintile 3 1.15 [0.84; 1.54]
Quintile 4 1.43 [1.08; 1.91]
Quintile 5 1.29 [0.95; 1.74]
Lips-mouth-pharynx Quintile 1 1 12.7
Quintile 2 0.98 [0.72; 1.35]
Quintile 3 1.08 [0.78; 1.47]
Quintile 4 1.29 [0.96; 1.72]
Quintile 5 1.52 [1.11; 2.05]
aPAF calculated with quintile 1 as reference.




























Figure 1 Proportion of excess cases associated with social deprivation in men.
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absence of individual data, we sought to quantify social in-
equalities in incidence of cancer, rather than understand
the underlying mechanisms. Using a neighborhood-based
index instead of a set of individual indicators has the ad-
vantage of incorporating both individual and collective de-






















Figure 2 Proportion of excess cases associated with social deprivatiobut this inevitably introduces an ecological bias for appro-
priate measurement of individual socioeconomic status.
Moreover, it considerably limits the search for causative fac-
tors explaining the links between social environment and
occurrence of cancer, individual measures of socioeconomic
status and behavioral risk factors being the best means to
explore in more depth the mechanisms responsible for the74
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http://www.biomedcentral.com/1471-2407/14/87influence of social environment on cancer risk. In addition,
the social environment was measured only at the time of
diagnosis, using the current address of patients but ignoring
their history of mobility, which could be geographical and
across social classes. Furthermore, we focused on the con-
sequences of previous social inequalities owing to the delay
between exposure and diagnosis. Despite the large number
of cases analyzed from cancer registries that have a high
level of case ascertainment, consistency and representative-
ness, a lack of power cannot be excluded for the less fre-
quent cancer sites.
Extrapolation of the PAFs needs further investigations
in order to ascertain their variability due to gradient in
relative risks, or to distribution across social quintiles.
Errors in interpretation can appear, as highlighted in the
article by Rockhill, et al. [16] with the use of the PAF.
Firstly, Rockhill et al. point out many errors possible
when analyzing multiple risk factors which is not the
case of our study. The second point is the overuse of the
word “explain” in the interpretation of the PAF. Rather
than explain, it measures the extent of the phenomenon
of deprivation on cancer incidence. The PAF should be
considered as the population resultant of the overall ex-
cess of cases in deprived compared with privileged
people. The socioeconomic environment is not a causal
factor of cancer in the biological sense of the term.
However, since much of the proximal risk factor is more
prevalent in the deprived, the socioeconomic environ-
ment can be considered as the "cause of the cause", a
distal determinant, pathways from deprivation to health
including different types of mediators such as behav-
ioral, community, social, educational, work-related, cul-
tural and political factors [28]. Such quantification of
social disparities at a community level points to the
need to jointly take actions in a universal approach and
also in approaches targeting deprived people, rather
than global population actions only that fail to reduce
social gradients because they generally benefit the more
affluent. The PAF makes it possible to estimate the col-
lective gain that could be obtained by public actions
aiming to reduce the social gradient of incidence by
measuring the extent of the population for which it is
necessary to lead effective cancer prevention.Conclusions
This study proposes an estimation of the proportion of
cancers associated with social deprivation and show how
by decreasing socioeconomic variation in incidence with
policies aiming to reduce social inequalities, an import-
ant impact could be made on the burden of cancer.Competing interests
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